A novel biological activity of praziquantel requiring voltage-operated Ca2+ channel beta subunits: subversion of flatworm regenerative polarity.
<h4>Background</h4>Approximately 200 million people worldwide harbour parasitic flatworm infections that cause schistosomiasis. A single drug-praziquantel (PZQ)-has served as the mainstay pharmacotherapy for schistosome infections since the 1980s. However, the relevant in vivo target(s)...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/54ba41af79114d84ae2c8babca92ef9a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:54ba41af79114d84ae2c8babca92ef9a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:54ba41af79114d84ae2c8babca92ef9a2021-11-25T06:33:18ZA novel biological activity of praziquantel requiring voltage-operated Ca2+ channel beta subunits: subversion of flatworm regenerative polarity.1935-27271935-273510.1371/journal.pntd.0000464https://doaj.org/article/54ba41af79114d84ae2c8babca92ef9a2009-06-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19554083/?tool=EBIhttps://doaj.org/toc/1935-2727https://doaj.org/toc/1935-2735<h4>Background</h4>Approximately 200 million people worldwide harbour parasitic flatworm infections that cause schistosomiasis. A single drug-praziquantel (PZQ)-has served as the mainstay pharmacotherapy for schistosome infections since the 1980s. However, the relevant in vivo target(s) of praziquantel remain undefined.<h4>Methods and findings</h4>Here, we provide fresh perspective on the molecular basis of praziquantel efficacy in vivo consequent to the discovery of a remarkable action of PZQ on regeneration in a species of free-living flatworm (Dugesia japonica). Specifically, PZQ caused a robust (100% penetrance) and complete duplication of the entire anterior-posterior axis during flatworm regeneration to yield two-headed organisms with duplicated, integrated central nervous and organ systems. Exploiting this phenotype as a readout for proteins impacting praziquantel efficacy, we demonstrate that PZQ-evoked bipolarity was selectively ablated by in vivo RNAi of voltage-operated calcium channel (VOCC) beta subunits, but not by knockdown of a VOCC alpha subunit. At higher doses of PZQ, knockdown of VOCC beta subunits also conferred resistance to PZQ in lethality assays.<h4>Conclusions</h4>This study identifies a new biological activity of the antischistosomal drug praziquantel on regenerative polarity in a species of free-living flatworm. Ablation of the bipolar regenerative phenotype evoked by PZQ via in vivo RNAi of VOCC beta subunits provides the first genetic evidence implicating a molecular target crucial for in vivo PZQ activity and supports the 'VOCC hypothesis' of PZQ efficacy. Further, in terms of regenerative biology and Ca(2+) signaling, these data highlight a novel role for voltage-operated Ca(2+) entry in regulating in vivo stem cell differentiation and regenerative patterning.Taisaku NogiDan ZhangJohn D ChanJonathan S MarchantPublic Library of Science (PLoS)articleArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENPLoS Neglected Tropical Diseases, Vol 3, Iss 6, p e464 (2009) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
spellingShingle |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 Taisaku Nogi Dan Zhang John D Chan Jonathan S Marchant A novel biological activity of praziquantel requiring voltage-operated Ca2+ channel beta subunits: subversion of flatworm regenerative polarity. |
description |
<h4>Background</h4>Approximately 200 million people worldwide harbour parasitic flatworm infections that cause schistosomiasis. A single drug-praziquantel (PZQ)-has served as the mainstay pharmacotherapy for schistosome infections since the 1980s. However, the relevant in vivo target(s) of praziquantel remain undefined.<h4>Methods and findings</h4>Here, we provide fresh perspective on the molecular basis of praziquantel efficacy in vivo consequent to the discovery of a remarkable action of PZQ on regeneration in a species of free-living flatworm (Dugesia japonica). Specifically, PZQ caused a robust (100% penetrance) and complete duplication of the entire anterior-posterior axis during flatworm regeneration to yield two-headed organisms with duplicated, integrated central nervous and organ systems. Exploiting this phenotype as a readout for proteins impacting praziquantel efficacy, we demonstrate that PZQ-evoked bipolarity was selectively ablated by in vivo RNAi of voltage-operated calcium channel (VOCC) beta subunits, but not by knockdown of a VOCC alpha subunit. At higher doses of PZQ, knockdown of VOCC beta subunits also conferred resistance to PZQ in lethality assays.<h4>Conclusions</h4>This study identifies a new biological activity of the antischistosomal drug praziquantel on regenerative polarity in a species of free-living flatworm. Ablation of the bipolar regenerative phenotype evoked by PZQ via in vivo RNAi of VOCC beta subunits provides the first genetic evidence implicating a molecular target crucial for in vivo PZQ activity and supports the 'VOCC hypothesis' of PZQ efficacy. Further, in terms of regenerative biology and Ca(2+) signaling, these data highlight a novel role for voltage-operated Ca(2+) entry in regulating in vivo stem cell differentiation and regenerative patterning. |
format |
article |
author |
Taisaku Nogi Dan Zhang John D Chan Jonathan S Marchant |
author_facet |
Taisaku Nogi Dan Zhang John D Chan Jonathan S Marchant |
author_sort |
Taisaku Nogi |
title |
A novel biological activity of praziquantel requiring voltage-operated Ca2+ channel beta subunits: subversion of flatworm regenerative polarity. |
title_short |
A novel biological activity of praziquantel requiring voltage-operated Ca2+ channel beta subunits: subversion of flatworm regenerative polarity. |
title_full |
A novel biological activity of praziquantel requiring voltage-operated Ca2+ channel beta subunits: subversion of flatworm regenerative polarity. |
title_fullStr |
A novel biological activity of praziquantel requiring voltage-operated Ca2+ channel beta subunits: subversion of flatworm regenerative polarity. |
title_full_unstemmed |
A novel biological activity of praziquantel requiring voltage-operated Ca2+ channel beta subunits: subversion of flatworm regenerative polarity. |
title_sort |
novel biological activity of praziquantel requiring voltage-operated ca2+ channel beta subunits: subversion of flatworm regenerative polarity. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2009 |
url |
https://doaj.org/article/54ba41af79114d84ae2c8babca92ef9a |
work_keys_str_mv |
AT taisakunogi anovelbiologicalactivityofpraziquantelrequiringvoltageoperatedca2channelbetasubunitssubversionofflatwormregenerativepolarity AT danzhang anovelbiologicalactivityofpraziquantelrequiringvoltageoperatedca2channelbetasubunitssubversionofflatwormregenerativepolarity AT johndchan anovelbiologicalactivityofpraziquantelrequiringvoltageoperatedca2channelbetasubunitssubversionofflatwormregenerativepolarity AT jonathansmarchant anovelbiologicalactivityofpraziquantelrequiringvoltageoperatedca2channelbetasubunitssubversionofflatwormregenerativepolarity AT taisakunogi novelbiologicalactivityofpraziquantelrequiringvoltageoperatedca2channelbetasubunitssubversionofflatwormregenerativepolarity AT danzhang novelbiologicalactivityofpraziquantelrequiringvoltageoperatedca2channelbetasubunitssubversionofflatwormregenerativepolarity AT johndchan novelbiologicalactivityofpraziquantelrequiringvoltageoperatedca2channelbetasubunitssubversionofflatwormregenerativepolarity AT jonathansmarchant novelbiologicalactivityofpraziquantelrequiringvoltageoperatedca2channelbetasubunitssubversionofflatwormregenerativepolarity |
_version_ |
1718413681154326528 |